CAS: 914613-36-8 - 1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2′-(2-ethyl-2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylate
Formula:C35H38N6O6
InChI:InChI=1S/C35H38N6O6/c1-4-41-38-32(37-39-41)28-15-10-9-14-27(28)25-20-18-24(19-21-25)22-40-31-29(16-11-17-30(31)36-34(40)44-5-2)33(42)45-23(3)46-35(43)47-26-12-7-6-8-13-26/h9-11,14-21,23,26H,4-8,12-13,22H2,1-3H3
InChI key:InChIKey=IPKUBVHJAZIDCZ-UHFFFAOYSA-N
SMILES:O=C(OC(OC(=O)C1=CC=CC=2N=C(OCC)N(C21)CC3=CC=C(C=C3)C4=CC=CC=C4C=5N=NN(N5)CC)C)OC6CCCCC6
Candesartan Cilexetil Related Compound F (1-(Cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-{[2'-(2-ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate)
Candesartan Cilexetil EP Impurity F (Candesartan Cilexetil USP Related Compound F, 2-Ethyl-Candesartan Cilexetil)
Ref: 4Z-C-018
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
(1RS)-1-[[(Cyclohexyloxy)carbonyl]-oxy]ethyl 2-Ethoxy-1-[[2'-(2-ethyl-2H-tetrazol-5-yl)-biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate
Controlled ProductRef: 86-MM0776.06-0025
25mg | 908.00 € |
2H-2-Ethyl Candesartan Cilexetil
Controlled ProductRef: TR-E900875
25mg | 324.00 € | ||
250mg | 2,074.00 € |
Candesartan cilexetil Related Compound F
Ref: 3D-PLB61336
5mg | 189.00 € | ||
10mg | 256.00 € | ||
25mg | 440.00 € | ||
50mg | 598.00 € | ||
100mg | 881.00 € |